View Older Stories View More Recent Stories

May 13, 2026 09:19AM Form SCHEDULE 13G/A Terns Pharmaceuticals, Filed by: Adage Capital Management, L.P.
May 13, 2026 09:19AM Form SCHEDULE 13G Inflection Point Acquisi Filed by: Adage Capital Management, L.P.
May 13, 2026 09:18AM Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
May 13, 2026 09:18AM Form SCHEDULE 13G Hennessy Capital Investm Filed by: Adage Capital Management, L.P.
May 13, 2026 09:16AM Form SCHEDULE 13G/A Seadrill Ltd Filed by: Adage Capital Management, L.P.
May 13, 2026 09:15AM Form SCHEDULE 13G/A RELMADA THERAPEUTICS, Filed by: Adage Capital Management, L.P.
May 13, 2026 09:15AM Form SCHEDULE 13G Fortress Value Acquisiti Filed by: Adage Capital Management, L.P.
May 13, 2026 09:14AM Form SCHEDULE 13G Forte Biosciences, Inc. Filed by: Adage Capital Management, L.P.
May 13, 2026 09:14AM Form SCHEDULE 13G/A NORTHPOINTE BANCSHARES Filed by: Adage Capital Management, L.P.
May 13, 2026 09:13AM Form SCHEDULE 13G FG Imperii Acquisition Filed by: Adage Capital Management, L.P.
May 13, 2026 09:13AM Form SCHEDULE 13G/A NABORS INDUSTRIES LTD Filed by: Adage Capital Management, L.P.
May 13, 2026 09:12AM Form SCHEDULE 13G Columbus Circle Capital Filed by: Adage Capital Management, L.P.
May 13, 2026 09:11AM Form SCHEDULE 13G/A Monopar Therapeutics Filed by: Adage Capital Management, L.P.
May 13, 2026 09:11AM Form SCHEDULE 13G Cambridge Acquisition Filed by: Adage Capital Management, L.P.
May 13, 2026 09:10AM Form SCHEDULE 13G/A Milestone Pharmaceutical Filed by: Adage Capital Management, L.P.
May 13, 2026 09:10AM Form SCHEDULE 13G Blue Water Acquisition Filed by: Adage Capital Management, L.P.
May 13, 2026 09:09AM Form SCHEDULE 13G Bleichroeder Acquisition Filed by: Adage Capital Management, L.P.
May 13, 2026 09:09AM Form SCHEDULE 13G/A Metropolitan Bank Holdin Filed by: Adage Capital Management, L.P.
May 13, 2026 09:08AM Form SCHEDULE 13G Averin Capital Acquisiti Filed by: Adage Capital Management, L.P.
May 13, 2026 09:08AM Form SCHEDULE 13G/A MeiraGTx Holdings plc Filed by: Adage Capital Management, L.P.
May 13, 2026 09:07AM Form SCHEDULE 13G/A INOVIO PHARMACEUTICALS, Filed by: Adage Capital Management, L.P.
May 13, 2026 09:06AM Form SCHEDULE 13G/A HERON THERAPEUTICS, INC. Filed by: Adage Capital Management, L.P.
May 13, 2026 09:06AM Form SCHEDULE 13G Atara Biotherapeutics, Filed by: Adage Capital Management, L.P.
May 13, 2026 09:05AM Form SCHEDULE 13G/A EyePoint, Inc. Filed by: Adage Capital Management, L.P.
May 13, 2026 09:05AM Form SCHEDULE 13G Armada Acquisition Corp. Filed by: Adage Capital Management, L.P.
May 13, 2026 09:04AM Form SCHEDULE 13G Archimedes Tech SPAC Filed by: Adage Capital Management, L.P.
May 13, 2026 09:03AM Form SCHEDULE 13G Aldabra 4 Liquidity Oppo Filed by: Adage Capital Management, L.P.
May 13, 2026 09:03AM Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: Adage Capital Management, L.P.
May 13, 2026 09:02AM Form SCHEDULE 13G/A Centessa Pharmaceuticals Filed by: Adage Capital Management, L.P.
May 13, 2026 09:00AM Form SCHEDULE 13G Abony Acquisition Corp. Filed by: Adage Capital Management, L.P.
May 13, 2026 09:00AM Form SCHEDULE 13G/A Adagio Medical Holdings, Filed by: Adage Capital Management, L.P.
May 8, 2026 06:52AM Artiva Biotherapeutics prices $300 million stock and warrant offering
May 8, 2026 06:52AM Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
May 7, 2026 07:00AM Parabilis Medicines Appoints Biopharmaceutical Finance Leader Alan M. Sebulsky to Board of Directors
May 4, 2026 06:37AM Cabaletta Bio prices $150 million stock offering at $2.90 per share
May 4, 2026 06:35AM Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering
Apr 28, 2026 07:00AM Climb Bio raises $110 million in private placement
Apr 28, 2026 07:00AM Climb Bio, Inc. Announces $110.0 Million Private Placement
Apr 21, 2026 10:13AM 4BIO Capital portfolio company Ray Therapeutics announces upsized and oversubscribed $125 Million Series B financing for vision restoration treatments
Apr 21, 2026 08:00AM Ray Therapeutics Announces Upsized and Oversubscribed $125 Million Series B Financing for Vision Restoration Treatments
Apr 13, 2026 08:30AM UNCF Announces Winners of Sixth Annual HBCU Stock Pitch Competition
Mar 31, 2026 06:45AM SCYNEXIS raises $40 million in private placement financing
Mar 31, 2026 06:45AM SCYNEXIS Announces $40.0 Million Private Placement
Mar 27, 2026 09:00AM First Tracks Biotherapeutics secures $145 million private placement ahead of spinoff
Mar 27, 2026 09:00AM AnaptysBio board approves First Tracks Biotherapeutics spin-off
Mar 27, 2026 09:00AM Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
Mar 27, 2026 09:00AM First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
Mar 27, 2026 08:02AM OnKure raises $150 million to advance cancer treatment programs
Mar 27, 2026 08:00AM OnKure Therapeutics Announces Oversubscribed $150 Million Private Placement to Advance Next-Generation PI3Kα Pan-Mutant Selective Inhibitor Candidates in Breast Cancer and Vascular Anomalies
Mar 25, 2026 04:05PM Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
View More Recent Stories View Older Stories